GP
Ghansham Panjabi Baird Latest Price Targets & Analyst Ratings
Main Sector
Consumer Discretionary
Ratings Past Year
20
Avg Return
Past Year
Past Year
8.6%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
55%
Neutral
45%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Consumer Discretionary
Healthcare
Industrials
Materials
Consumer Discretionary
Packaging & Containers
Healthcare
Medical Instruments & Supplies
Industrials
Specialty Business Services
Materials
Chemicals
Specialty Chemicals
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $125 |
15%
upside
| 2 | -0.05% |
0
%
| 4 Mar ‘26 yesterday |
|
|
|
Neutral
Maintained
| $60 |
9%
upside
| 1 | – |
–
| 18 Feb ‘26 15 days ago |
|
|
|
Outperform
Upgraded
| $50 |
9%
upside
| 2 | +7.1% |
0
%
| 7 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $35 |
11%
upside
| 1 | – |
–
| 7 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $18 |
61%
upside
| 2 | +0.32% |
0
%
| 7 Jan ‘26 1 month ago |
|
|
|
Neutral
Downgraded
| $42 |
0%
downside
| 1 | – |
–
| 18 Dec ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $145 |
6%
upside
| 1 | +18% |
0
%
| 3 Nov ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $50 |
2%
downside
| 1 | +24% |
0
%
| 13 Aug ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $110 |
1%
downside
| 2 | +8.8% |
–
| 23 Jul ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $125 |
30%
upside
| 2 | +3.4% |
0
%
| 3 Jul ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $75 |
17%
upside
| 2 | +11% |
0
%
| 27 Jun ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $100 |
28%
upside
| 1 | +6.3% |
0
%
| 8 May ‘25 10 months ago |
|
|
|
Neutral
Maintained
| $5 |
5%
downside
| 1 | – |
–
| 7 May ‘25 10 months ago |
|
|
|
Outperform
Maintained
| $210 |
12%
upside
| 1 | +10% |
0
%
| 24 Apr ‘25 10 months ago |
|